Overview
Pancreatic Adenocarcinoma is an aggressive and deadly form of cancer that starts in the cells of the pancreas. It is the fourth leading cause of cancer-related deaths in the United States, due to its tendency to spread quickly and its difficulty to detect in the early stages. Symptoms can include abdominal pain, weight loss, yellowing of the skin, and fatigue. Treatment options include chemotherapy, radiation, and surgery. With early detection and treatment, survival rates can be improved and quality of life can be extended for those affected by Pancreatic Adenocarcinoma.
Research published in this journal
6 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 6 articles above have been cited 10 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2023 · kulak burun boğaz ve baş boyun cerrahisi dergisi
-
2022 · European Archives of Oto-Rhino-Laryngology
-
M. Topuz et al. · 2022 · European Archives of Oto-Rhino-Laryngology
-
J. H. Maués et al. · 2020 · Biomolecules
-
2020 · Biomolecules
-
2020 · Bioscience Reports
-
2017 · Journal of Otolaryngology Advances
-
M. Glade et al. · 2015 · Nutrition (Burbank, Los Angeles County, Calif.)
A sample of recent works citing this journal's research on Pancreatic Adenocarcinoma, linking to each citing work.